AKT1 and cancer: Akt, a PI3K downstream molecule, causes conformational changes through a series of actions, exposing the phosphorylation sites of Thr308 and Ser473 in the kinase domain and C-terminal domain, respectively [56], which promotes the cancer cell growth and provides resistance to cell apoptosis [34].